Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 16, Issue 8, Pages 811-826Publisher
TAYLOR & FRANCIS AS
DOI: 10.1080/14737159.2016.1194758
Keywords
Ovarian carcinoma; serum; tissue; immune biomarkers; exosomes; microRNAs
Categories
Funding
- Foundation for Polish Science [2011/186]
- Narodowe Centrum Nauki (National Science Center) [2013/11/B/NZ6/02790]
- NIH [R01 CA-16862]
Ask authors/readers for more resources
Introduction: Ovarian cancer (OvCa) is among the most common types of cancer and is the leading cause of death from gynecological malignancies in western countries. Cancer biomarkers have a potential for improving the management of OvCa patients at every point from screening and detection, diagnosis, prognosis, follow up, response to therapy and outcome.Areas covered: The literature search has indicated a number of candidate biomarkers have recently emerged that could facilitate the molecular definition of OvCa, providing information about prognosis and predicting response to therapy. These potentially promising biomarkers include immune cells and their products, tumor-derived exosomes, nucleic acids and epigenetic biomarkers.Expert commentary: Although most of the biomarkers available today require prospective validation, the development of noninvasive liquid biopsy-based monitoring promises to improve their utility for evaluations of prognosis, response to therapy and outcome in OvCa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available